Crystalline Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Crystalline Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-155,000	Closed	-$6.1M	–	158
2023 Q2	$6.1M	Buy	+155,000	New	+$5.47M	4.32%	4

Crystalline Management's ISEE Position: Q3 2023 in Review

Crystalline Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 155,000 shares — an estimated $6.1M sold.

Crystalline Management first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $6.1M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Crystalline Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Crystalline Management sold 155,000 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $6.1M.
Crystalline Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Crystalline Management's IVERIC bio, Inc. Common Stock position peaked at $6.1M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Crystalline Management's 13F filing for Q3 2023, filed 13 Nov 2023.